Waverley Pharma Inc - ESG Rating & Company Profile powered by AI
Alternative companies in the scoring peer group for Waverley Pharma Inc are shown below. Scroll down to the bottom of this webpage for potential risks for Waverley Pharma Inc based on industry, location and size. If you are employed by Waverley Pharma Inc and you wish to use your ESG aseessment, please get in touch.
Waverley Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.4; made up of an environmental score of 0.0, social score of 1.6 and governance score of 2.7.
1.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2372 | Yifan Pharmaceutical Co Ltd | 1.5 | Low |
| 2372 | iNtRON Biotechnology Inc | 1.5 | Low |
| 2416 | Waverley Pharma Inc | 1.4 | Low |
| 2416 | Aerpio Pharmaceuticals Inc | 1.4 | Low |
| 2416 | Anterogen Co Ltd | 1.4 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Waverley Pharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Waverley Pharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Waverley Pharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Waverley Pharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Waverley Pharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Waverley Pharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Waverley Pharma Inc offer flexible work?
Sign up for free to unlockDoes Waverley Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Waverley Pharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Waverley Pharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Waverley Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Waverley Pharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Waverley Pharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Waverley Pharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Waverley Pharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Waverley Pharma Inc disclose water use targets?
Sign up for free to unlockDoes Waverley Pharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Waverley Pharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Waverley Pharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Waverley Pharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Waverley Pharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Waverley Pharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Waverley Pharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Waverley Pharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Waverley Pharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Waverley Pharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Waverley Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Waverley Pharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Waverley Pharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Waverley Pharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Waverley Pharma Inc disclose its waste policy?
Sign up for free to unlockDoes Waverley Pharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Waverley Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Waverley Pharma Inc disclose energy use targets?
Sign up for free to unlockDoes Waverley Pharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Waverley Pharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Waverley Pharma Inc
These potential risks are based on the size, segment and geographies of the company.
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the United Kingdom, European Union, and North America. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising capecitabine, temozolomide, and erlotinib. Its products under development include injectable generic chemotherapy drugs, such as WAV-101 for the treatment of non-small cell lung cancer and pleural mesothelioma; and WAV-102 to treat multiple myeloma and mantle cell lymphoma. The company has a collaboration with the University of Manitoba for the development of a synthetic library of chloroquine analogs to treat COVID-19. Waverley Pharma Inc. is headquartered in Winnipeg, Canada.